Filing Details
- Accession Number:
- 0001127602-13-017674
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-21 15:19:57
- Reporting Period:
- 2013-05-17
- Filing Date:
- 2013-05-21
- Accepted Time:
- 2013-05-21 15:19:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1444683 | Jatin Shah | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Sr Vp & Chief Scientific Offic | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-17 | 1,500 | $15.47 | 2,990 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-17 | 1,090 | $119.64 | 1,900 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-05-17 | 1,620 | $15.47 | 3,520 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-17 | 1,178 | $119.57 | 2,342 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option Right to Buy | Disposition | 2013-05-17 | 1,500 | $0.00 | 1,500 | $15.47 |
Common Stock | Employee Stock Option Right to Buy | Disposition | 2013-05-17 | 1,620 | $0.00 | 1,620 | $15.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,620 | 2016-08-16 | No | 4 | M | Direct | |
0 | 2016-08-16 | No | 4 | M | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $119.56 to $119.59. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- Exercisable in 5 equal annual installments beginning 8/16/2007.